The Extraordinary General Meeting of Shareholders 2020 was held at 8:00 am, Thursday December 17, 2020 at Function Room - 2nd Floor, Hanoi Hotel, D8, Giang Vo street, Ba Dinh district, city Hanoi.

At the opening of the meeting, Ms. Do Thi Mai, on behalf of the Organizing Committee of the General Meeting of Shareholders of Vietnam Japan Medical Instrument Joint Stock Company, announced the reason for the opening of the meeting and introduced the participants.

Executive Congress, the Presidium includes:

• Mr. Nguyen Huy Tuan - Chairman of the Board of Directors (Chairman of the meeting)
• Mr. Nguyen Viet Cuong - Member of the Board of Directors (Member of the Presidium)
• Mr. Hoang Van Kien - Deputy General Director (Member of the Presidium)

The meeting conducted voting and approved the following contents:

• Approving the amendment and supplementation of the Company's Charter on organization and activities.
• Approving the amendment and supplementation of the Internal Management Regulations of the Company.
• Approving the dismissal and an additional election of members of the Board of Directors and the Supervisory Board for the term 2016-2021.
• Approving the establishment of subcommittees directly under the Board of Directors of the Company.
• Approving the amendment and supplementation of the business lines of the Company.
• Approving the changing of the title of legal representative.

The meeting elected additional members of the Board of Directors, members of the Supervisory Board in the form of cumulative voting and secret ballot.

The list of elected members of the Board of Directors for the 2016-2021 term:

• Mr.: Cao Tien Dung
• Ms.: Nguyen Thi Hanh
• Mr.: Hoang Diep
• Mr.: Nguyen Lan Viet Anh
• Mr.: Hoang Van Kien
• Mr.: Tran Ngoc Khanh

Awarded a member of the Supervisory Board for the 2016-2021 tenure:

• Mr. Nguyen Van Vy

At the meeting, the Chairman had a few shares in the discussion:

“The new group of shareholders are professional investors and have a deep understanding about the health sector. Besides, very enthusiastic and committed enough to bring the JVC to develop. This is one of the reasons that the last shareholders DI choose carefully when deciding to divest a new group of shareholders.

Upcoming development orientation: Contributing to the development of health infrastructure for Vietnamese people, with Japanese standards and low prices, helping Vietnamese people to easily access them. At the same time, JVC has a basic system foundation, good distributor relationships that will maximize its existing advantages, research and expand new businesses related to health due to high potentianl and people’s demand"